A Trial of SHR1701 Plus Chemotherapy in Patients With Gastric or Gastroesophageal Cancer

NCT04950322 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

737

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric or Gastroesophageal Junction Cancer

Interventions

DRUG: SHR-1701、CAPOX
DRUG: Placebo、CAPOX

Sponsor

Suzhou Suncadia Biopharmaceuticals Co., Ltd.